Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Mesh Bio logo — Multidimensional Health Intelligence Platform for digital tw...

Mesh Bio

Multidimensional Health Intelligence Platform for digital twin and computational biology enabled care delivery

Founded 2018 Singapore Singapore 27 employees Series A Total: $5.30M AI, Analytics +3

General Information

Company Name Mesh Bio
Founded Year 2018
Location Singapore Singapore
Employees 27
Industries AI, Analytics, Biotechnology +2
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Tiered Pricing, Usage Based
Offices as of Nov 2026
Singapore, Singapore
Social

BounceWatch is an independent company data service, not affiliated with Mesh Bio. To contact Mesh Bio, visit meshbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Mesh Bio compare?

A PDF of Mesh Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Mesh Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 15, 2026

Mesh Bio spoke at the Angelini Ventures Symposium.

Mesh Bio a competitor of yours? Have our desk watch it

About Mesh Bio

Mesh Bio, founded in 2018, is a fast-growing digital health startup based in Singapore. The company specializes in developing AI-powered clinical decision support, analytics, and automation solutions tailored for healthcare providers. With its mission encapsulated in its slogan, "Multidimensional Health Intelligence Platform for digital twin and computational biology enabled care delivery", Mesh Bio is aiming to transform healthcare delivery with digital solutions.

Operating at the intersection of AI, Analytics, Biotechnology, Health Care, and Information Technology, the company has cultivated an environment that emphasizes personal excellence, career growth, and diversity.

Mesh Bio recently secured a $3.50M Series A investment on 12 October 2023, attracting investors like East Ventures, Elev8.VC, Seed Capital, and Selvedge Venture. This funding round accentuates the company’s potential to further expand its innovative offerings in the healthcare sector.

Business keywords: digital health, clinical decision support, predictive analytics, chronic disease management, healthcare automation, AI powered solutions, computational biology, digital twin technology, personalized medicine, precision medicine, risk assessment, systems biology, health screening innovation, health intelligence platform, healthtech

Services & Products

AI-powered health screening
Predictive disease progression tools
Clinical workflow optimization
Automated reporting
Risk stratification
Patient engagement solutions

Target Customers

Healthcare providers Private healthcare clinics Diagnostic laboratories Occupational health services Pharmaceutical companies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $3.50M 4
East Ventures Elev8.VC Seed Capital
East Ventures, Elev8.VC +2
12 Oct 2023
Seed Round $1.80M 4
Elev8.VC SEEDS Capital Citrine Capital
Elev8.VC, SEEDS Capital +2
10 Mar 2021

Mesh Bio Alternatives & Competitors

View All Alternatives
Mesh Bio vs
CLINICOM
CLINICOM United States

World’s First Comprehensive DSM based Clinical Decision support platform and Augmented Intelligence...

Seed
34 employees
Health Care, Health and Wellness
Compare Mesh Bio vs CLINICOM
Mesh Bio vs
Carenostics
Carenostics United States

Addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and...

Seed
13 employees
AI, Biotechnology
Compare Mesh Bio vs Carenostics
Mesh Bio vs
Holmusk
Holmusk United States

Raising the standards for real-world evidence generation to transform research and care for behavior...

Venture round
111 employees
AI, Analytics
Also compare with: Mesh Bio vs Unlearn.AI Unlearn.AI View all alternatives

FAQ About Mesh Bio

Multidimensional Health Intelligence Platform for digital twin and computational biology enabled care delivery
Mesh Bio was founded in 2018.
Mesh Bio is headquartered in Singapore. As of Nov 2026, it also has offices in Singapore, Singapore.
Mesh Bio operates in AI, Analytics, Biotechnology, Health Care and Information Technology. Its work centres on digital health, clinical decision support, predictive analytics and chronic disease management. Its customers include Healthcare providers, Private healthcare clinics and Diagnostic laboratories.
Mesh Bio has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Tiered Pricing and Usage Based.
Mesh Bio has approximately 27 employees.
Mesh Bio has completed 2 funding rounds, raising a total of $5.30M. The latest funding stage is Series A.
Mesh Bio offers: AI-powered health screening, Predictive disease progression tools, Clinical workflow optimization, Automated reporting, Risk stratification, Patient engagement solutions.
Top alternatives and competitors to Mesh Bio include CLINICOM, Carenostics, Holmusk, INHERET, Inc., Heads Up. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mesh Bio and CLINICOM are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mesh Bio, https://bouncewatch.com/company/mesh-bio, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout